Ripazepam
![]() | |
Identifiers | |
---|---|
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
Chemical and physical data | |
Formula | C15H16N4O |
Molar mass | 268.320 g·mol−1 |
3D model (JSmol) | |
| |
| |
![]() ![]() |
Ripazepam is a pyrazolodiazepinone derivative structurally related to certain benzodiazepine drugs, especially zolazepam. It has anxiolytic effects.[1][2]
See also
[edit]References
[edit]- ^ Fitzgerald JE, de la Iglesia FA, McGuire EJ (April 1984). "Carcinogenicity studies in rodents and ripazepam, a minor tranquilizing agent". Fundamental and Applied Toxicology. 4 (2 Pt 1): 178–90. doi:10.1016/0272-0590(84)90118-0. hdl:2027.42/24852. PMID 6724192.
- ^ Baraldi PG, Manfredini S, Periotto V, Simoni D, Guarneri M, Borea PA (May 1985). "Synthesis and interaction of 5-(substituted-phenyl)-3-methyl-6,7-dihydropyrazolo[4,3-e] [1,4]diazepin-8(7H)-ones with benzodiazepine receptors in rat cerebral cortex". Journal of Medicinal Chemistry. 28 (5): 683–5. doi:10.1021/jm50001a025. PMID 2985787.